These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7640349)
1. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1. Sandler S; Sternesjö J Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349 [TBL] [Abstract][Full Text] [Related]
2. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo. Sternesjö J; Welsh N; Sandler S Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets. Sternesjö J; Sandler S Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Sandler S; Bendtzen K; Eizirik DL; Welsh M Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746 [TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice. Sternesjö J; Sandler S J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328 [TBL] [Abstract][Full Text] [Related]
6. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function. Welsh N; Sandler S Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Sandler S; Andersson A; Hellerström C Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437 [TBL] [Abstract][Full Text] [Related]
8. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans]. Chen H; Cai D; Wang M; Liu H Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1. Sandler S; Welsh N Biochem Biophys Res Commun; 1993 Sep; 195(2):859-65. PubMed ID: 8373422 [TBL] [Abstract][Full Text] [Related]
11. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets. Eizirik DL; Welsh N; Hellerström C J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway. Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978 [TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase. Andersson AK; Flodström M; Sandler S Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. Rydgren T; Sandler S Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118 [TBL] [Abstract][Full Text] [Related]
15. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190 [TBL] [Abstract][Full Text] [Related]
16. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets. Bleich D; Chen S; Bursten SL; Nadler JL Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma. Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798 [TBL] [Abstract][Full Text] [Related]
18. Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1 beta effects in pancreatic islets. Laychock SG; Bauer AL Endocrinology; 1996 Aug; 137(8):3375-85. PubMed ID: 8754764 [TBL] [Abstract][Full Text] [Related]
19. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap. Rydgren T; Bengtsson D; Sandler S Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets. Welsh N; Sandler S Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]